Envista Announces Participation in Stifel 2022 Jaws & Paws Conference
Envista Holdings Corporation (NYSE: NVST) will participate in the Stifel 2022 Jaws & Paws Conference on June 1, 2022, from 9:45 to 10:15 AM EST in New York City.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Envista Holdings Corporation (NYSE: NVST) will participate in the Stifel 2022 Jaws & Paws Conference on June 1, 2022, from 9:45 to 10:15 AM EST in New York City. Investors can access live streams or recordings via the company's Investor Relations website. Envista is a leading global dental products company, comprising over 30 trusted brands that offer dental consumables, solutions, and technology. The company focuses on improving patient care and is well-positioned in attractive segments of the dental industry.
Positive
- Participation in Stifel 2022 Jaws & Paws Conference enhances visibility.
- Strong portfolio of over 30 trusted dental brands.
- Well-positioned in attractive segments of the dental products industry.
Negative
- None.
Details
News Market Reaction – NVST
The recorded move for NVST in the trading session of this news was -0.14%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BREA, Calif., May 19, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Stifel 2022 Jaws & Paws Conference on Wednesday, June 1, 2022, from 9:45 – 10:15 AM EST in New York, New York.
Investors will be able to access any applicable live streams or recordings through Envista's Investor Relations website under the subheading Events and Presentations.
About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, DEXIS, Ormco, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a broad range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.
For Further Information
Stephen Keller
Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
Fax: (714) 817-5450
View original content to download multimedia:https://www.prnewswire.com/news-releases/envista-announces-participation-in-stifel-2022-jaws--paws-conference-301551584.html
SOURCE Envista Holdings Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.